Which federal agency does American Medical Association comment on most?

American Medical Association is most active at the Food and Drug Administration.

← OpenPolis Sign in

American Medical Association

Unclaimed

Industry

Nonprofit Organization Management

Staff

2,600

330 North Wabash Avenue, Chicago, Illinois

Phone

+1 800-621-8335

Website

ama-assn.org

Engagement overview

American Medical Association has filed 287 public comments across 235 dockets at 24 federal agencies, most actively at the Food and Drug Administration.

American Medical Association

Engagement overview

Is this your organization?

Agency footprint

Dockets (235)

List of Bulk Drug Substances For Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Notice

Notices

Excepted Fertility Benefits

Improving Wage Protections for the Temporary and Permanent Employment of Certain Foreign Nationals in the United States

Request for Public Comment Regarding Making Improvements to the Premerger Notification and Report Form

Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions To Unleash Prosperity

Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care

Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media

NPRM COMMENTS CLOSE ON 12/19/25; PRA COMMENTS CLOSE ON 1/20/26; Public Charge Ground of Inadmissibility

Weighted Selection Process for Registrants and Petitioners Seeking to File Cap-Subject H-1B Petitions

Food Safety and Inspection Service Ultra-Processed Foods; Request for Information

Food Labeling: Front-of-Package Nutrition Information

Reproductive Health Services

Repeal of Greenhouse Gas Emissions Standards for Fossil Fuel-Fired Electric Generating Units

Alcohol Facts Statements in the Labeling of Wines, Distilled Spirits, and Malt Beverages

Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

Expansion of NIOSH B Reader Certification Eligibility - Request for Information

Approach for Improving the Performance Evaluation of Pulse Oximeter Devices Taking Into Consideration Skin Pigmentation, Race and Ethnicity

Proposed Modifications to the HIPAA Security Rule to Strengthen the Cybersecurity of ePHI

Request for Public Comments on the Scientific Report of the 2025 Dietary Guidelines Advisory Committee

Recommendations for Determining Risk of Human Immunodeficiency Virus (HIV) Infection for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Draft Guidance for Industry

Enhancing Coverage of Preventive Services under the Affordable Care Act

Voluntary Sodium Reduction Goals: Target Mean and Recommended Maximum Concentrations for Sodium in Commercially Processed, Packaged, and Prepared Foods

Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability

Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability

Considerations in Demonstrating Interchangeability With a Reference Product

Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V)

Cyber Incident Reporting for Critical Infrastructure Act (CIRCIA) Reporting Requirements

Request for Information on Consolidation in Health Care Markets

Solicitation for Public Comment to Understand Lack of Competition and Contracting Practices that May be Contributing to Drug Shortages

Ensuring Safe Accommodations for Air Travelers With Disabilities Using Wheelchairs

Development of a Universal Symbol for Language Assistance Services in Health Settings

Collection of Race and Ethnicity Data in Clinical Trials

National Primary Drinking Water Regulations: Lead and Copper Rule Improvements

Medical Devices; Laboratory Developed Tests

21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking

Modernizing H-1B Requirements, Providing Flexibility in the F-1 Program, and Program Improvements Affecting Other Nonimmigrant Workers

Request for Information; Coverage of Over-the-Counter Preventive Services

Discrimination on the Basis of Disability in Health and Human Services Programs or Activities

Requirements Related to the Mental Health Parity and Addiction Equity Act

Health and Human Services Grants Regulation

Questions and Answers About Dietary Guidance Statements in Food Labeling: Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

Draft Merger Guidelines for Public Comment

Health Breach Notification Rule

HIPAA Privacy Rule to Support Reproductive Health Care Privacy

Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing

Non-Compete Clause Rule

2025 Dietary Guidelines Advisory Committee

Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments

Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products

AR50-Interim Final Rule-Emergent Suicide Care

Safeguarding the Rights of Conscience as Protected by Federal Statutes

Confidentiality of Substance Use Disorder (SUD) Patient Records

Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Health Care; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

AR55-CHAMPVA Coverage of Audio-Only Telehealth, Mental Health Services, and Cost Sharing for Certain Contraceptive Services and Contraceptive Products Approved, Cleared, or Granted by FDA

Nondiscrimination in Health Programs and Activities

Health Care Professionals Practicing Via Telehealth (2900-AQ59)

Temporary Increase of the Automatic Extension Period of Employment Authorization and Documentation for Certain Renewal Applicants

Affordability of Employer Coverage for Family Members of Employees (REG-114339-21)

Solicitation for Public Comments on the Impact of Prescription Benefit Managers’ Business Practices

Request for Information on Merger Enforcement

COVID-19 Emergency Temporary Standard Rulemaking

Public Charge Ground of Inadmissibility

Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids

AR01-Proposed Rule-VA Pilot Program on Graduate Medical Education and Residency

Security Bars and Processing; Delay of Effective Date

COVID-19 Vaccination and Testing Emergency Temporary Standard Rulemaking

Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings

Deferred Action for Childhood Arrivals

Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis; Public Workshop; Request for Comments

Interventions to Prevent Work-Related Stress and Support Health Worker Mental Health; Request for Information

Procedures for Credible Fear Screening and Consideration of Asylum, Withholding of Removal, and CAT Protection Claims by Asylum Officers

Identifying Barriers Across U.S. Citizenship and Immigration Services (USCIS) Benefits and Services; Request for Public Input

Request for Information on Data Sources and Methods for Determining Prevailing Wage Levels for the Temporary and Permanent Employment of Certain Immigrants and Non-Immigrants in the United States

Federal Registers, Written and Electronic Submissions (that do not include a Docket Number or ID_2021)